Articles tagged with "upadacitinib"

ajt/shutterstock.com

FDA Approves Upadacitinib for Non-Radiographic Axial Spondyloarthritis

October 27, 2022 • By Michele B. Kaufman, PharmD, BCGP

Updates on PsA: Insights into the Latest Psoriatic Arthritis Treatments & Research

August 11, 2022 • By Jason Liebowitz, MD

FDA Discussed 2021 Drug Warnings & Approvals at ACR Annual Meeting

December 1, 2021 • By Thomas R. Collins

Trial Pits Upadacitinib vs. Adalimumab for Psoriatic Arthritis

October 14, 2021 • By Vanessa Caceres

Tips for Transitioning Patients from Pediatric to Adult Rheumatology Care

October 14, 2021 • By Sarah D. Bayefsky, MD, Kimberly DeQuattro, MD, & Rebecca E. Sadun, MD, PhD

FDA Requires New Boxed Warnings on JAK Inhibitors, Places Restrictions on Use

September 1, 2021 • By Keri Losavio

Health Canada Approves Upadacitinib to Treat Adults with PsA

July 6, 2021 • By Michele B. Kaufman, PharmD, BCGP

Upadacitnib for RA: Researchers Compared Upadacitinib with Placebo & Adalimumab in Patients with RA & an Inadequate Response to Methotrexate

March 9, 2021 • By Vanessa Caceres

European Commission Approves Upadacitinib for Psoriatic Arthritis & Ankylosing Spondylitis

February 4, 2021 • By Michele B. Kaufman, PharmD, BCGP

Upadacitinib Safety Similar to Other Jakinibs for RA

November 16, 2020 • By Lisa Rapaport